CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$84.2M
AUM Growth
+$472K
Cap. Flow
+$1.64M
Cap. Flow %
1.94%
Top 10 Hldgs %
44.61%
Holding
75
New
3
Increased
26
Reduced
8
Closed
13
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
SABR icon
Sabre
SABR
+$1.72M
2
WKC icon
World Kinect Corp
WKC
+$1.36M
3
BRKL icon
Brookline Bancorp
BRKL
+$1.26M
4
ALCO icon
Alico
ALCO
+$641K
5
OSPN icon
OneSpan
OSPN
+$599K

Top Sells

Rank Stock Value
1
AI icon
C3.ai
AI
+$1.34M
2
CBAY icon
Cymabay Therapeutics
CBAY
+$1M
3
B icon
Barrick Mining
B
+$945K
4
AEM icon
Agnico Eagle Mines
AEM
+$780K
5
YOU icon
Clear Secure
YOU
+$686K

Sector Composition

Rank Sector Weight
1 Healthcare 36.45%
2 Industrials 11.96%
3 Energy 9.91%
4 Financials 9.6%
5 Consumer Discretionary 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VTRS icon
26
Viatris
VTRS
$20B
$1.2M 1.43%
125,000
+25,000
+25% +$277K
2020 Q4
9 quarters
SVC
27
Service Properties Trust
SVC
$758M
$1.2M 1.42%
24,000
+4,000
+20% +$185K
2021 Q3
6 quarters
RBCAA icon
28
Republic Bancorp
RBCAA
$1.78B
$1.17M 1.39%
27,500
+9,500
+53% +$410K
2020 Q4
9 quarters
SFE
29
DELISTED
Safeguard Scientifics, Inc.
SFE
$1.16M 1.37%
671,671
– –
2020 Q4
9 quarters
PRTK
30
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.14M 1.36%
450,000
+105,000
+30% +$207K
2020 Q4
9 quarters
TRC icon
31
Tejon Ranch
TRC
$438M
$1.1M 1.3%
60,000
-5,000
-8% -$96K
2020 Q4
9 quarters
AVIR icon
32
Atea Pharmaceuticals
AVIR
$371M
$1.09M 1.29%
325,000
+50,000
+18% +$203K
2021 Q2
7 quarters
FIS icon
33
Fidelity National Information Services
FIS
$18.3B
$1.09M 1.29%
20,000
– –
2022 Q3
2 quarters
USAP icon
34
DELISTED
Universal Stainless & Alloy
USAP
$1.07M 1.28%
115,000
– –
2021 Q2
7 quarters
FNF icon
35
Fidelity National Financial
FNF
$10.5B
$1.05M 1.24%
30,000
+5,000
+20% +$197K
2022 Q2
3 quarters
DIT icon
36
AMCON Distributing
DIT
$61.3M
$1M 1.19%
9,000
+750
+9% +$85.5K
2020 Q4
9 quarters
KD icon
37
Kyndryl
KD
$2.57B
$886K 1.05%
60,000
– –
2021 Q4
5 quarters
VTOL icon
38
Bristow Group
VTOL
$1.17B
$840K 1%
37,500
+2,500
+7% +$66.3K
2020 Q4
9 quarters
RNAC icon
39
Cartesian Therapeutics
RNAC
$192M
$834K 0.99%
20,000
– –
2020 Q4
9 quarters
BATL icon
40
Battalion Oil
BATL
$59M
$821K 0.97%
125,000
– –
2020 Q4
9 quarters
BCDA icon
41
BioCardia
BCDA
$14M
$642K 0.76%
21,933
– –
2020 Q4
9 quarters
ARKOW icon
42
DELISTED
ARKO Corp Warrant
ARKOW
$597K 0.71%
400,000
– –
2021 Q1
8 quarters
ELDN icon
43
Eledon Pharmaceuticals
ELDN
$183M
$554K 0.66%
234,800
– –
2021 Q1
8 quarters
HRTX icon
44
Heron Therapeutics
HRTX
$68.7M
$529K 0.63%
350,000
+100,000
+40% +$250K
2020 Q4
9 quarters
SPPI
45
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$506K 0.6%
675,000
– –
2020 Q4
9 quarters
ELTX icon
46
Elicio Therapeutics
ELTX
$48.5M
$464K 0.55%
80,000
+6,782
+9% +$45.2K
2021 Q1
8 quarters
PAGP icon
47
Plains GP Holdings
PAGP
$5.37B
$459K 0.55%
35,000
-15,000
-30% -$197K
2020 Q4
9 quarters
GANX icon
48
Gain Therapeutics
GANX
$57.6M
$434K 0.52%
90,000
-20,000
-18% -$81.7K
2021 Q2
7 quarters
CRIS icon
49
Curis
CRIS
$1.45M
$328K 0.39%
1,375
+750
+120% +$198K
2022 Q4
1 quarter
BCEL
50
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$314K 0.37%
275,000
– –
2020 Q4
9 quarters
1
2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q1 2023 Portfolio in Review

As of Q1 2023, CM Management held 75 positions worth $84.2M, up 0.56% from $83.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

CM Management's Q1 2023 filing shows 3 new, 26 increased, 8 reduced and 13 closed positions. Its largest new stake was Sabre: 300,000 shares worth $1.29M. The largest sale was C3.ai, an estimated $1.34M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Industrials and Energy.

  • CM Management's largest Q1 2023 buy was Sabre: 300,000 shares worth $1.29M.
  • CM Management added most to Brookline Bancorp in Q1 2023, an estimated $1.26M increase.
  • CM Management's biggest Q1 2023 reduction was Cytokinetics, cutting an estimated $612K.
  • CM Management fully exited C3.ai in Q1 2023, selling an estimated $1.34M.
  • CM Management's ten largest holdings make up 45% of its $84.2M portfolio in Q1 2023.
  • CM Management opened 3 new positions and closed 13 in Q1 2023.
  • CM Management's portfolio value rose 0.56% quarter-over-quarter to $84.2M.

Based on CM Management's 13F filing for Q1 2023, filed 8 May 2023.